Neoadjuvant Immunotherapy in Rare Mutations Localized NSCLC

Clinical trial NCT05800340 · RECRUITING

Trial details

NCT number: NCT05800340
Sponsor: Guangdong Provincial People's Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Non-Small Cell Lung Cancer RET Driver Mutation BRAF V600 Mutation Erb-B2 Receptor Tyrosine Kinase Exon 20 Mutation MET Amplification MET Exon 14 Skipping Mutation

Start date: 2023-04-04
Primary completion: 2024-12-31
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.